Masters in Lipidology

test

Advance Your Expertise with the NLA’s Masters in Lipidology Course

The National Lipid Association’s (NLA) Masters in Lipidology course is an advanced training program designed for healthcare professionals specializing in lipid management. Newly revised for 2024, this course provides in-depth education on complex lipid disorders, offering expert-led discussions, case-based learning, and practical applications for real-world clinical practice.

Who Should Attend?

This course is tailored for experienced healthcare professionals seeking to refine their expertise in lipidology and elevate their role as consultative lipid specialists, including:
Physicians (Cardiologists, Endocrinologists, Lipidologists, and other specialists)
Physician Assistants
Nurse Practitioners
Pharmacists
Registered Dietitians
Other healthcare professionals with a strong background in lipid management

Why Attend?

Expert-Led Case Discussions – Learn from top faculty and guest panelists as they navigate real-world complex lipid cases.
Comprehensive Clinical Insights – Gain a deeper understanding of challenging lipid disorders, treatment strategies, and key clinical trial data.
Practical Application – Enhance your ability to develop personalized treatment plans and confidently manage high-risk patients.
Network with Leaders in Lipidology – Engage with experts and peers in the field to expand your professional connections.

2025 Course Offerings

May 28-29, 2025 | In-Person | Miami, FL | REGISTER HERE
October 16-17, 2025 | In-Person | Scottsdale, AZ | REGISTER HERE

(This course is offered as a 2-day pre-conference event before NLA’s Clinical Lipid Updates [CLU] and Scientific Sessions.)

Course Curriculum

  • Complex Cases and Consultative Lipidology
  • Recognition and Diagnosis of Complex Lipid Disorders
  • Treatment Strategies and Pharmacologic Approaches
  • Interpretation of Key Clinical Trial Data
  • Developing Individualized Treatment Plans
  • Expert Panel Discussions on Challenging Cases

Registration & Pricing

NLA Member: $750
Non-Member: $1,250
Trainees: $395
(Pricing subject to change)

Elevate your lipidology expertise and take the next step toward becoming a trusted consultative lipid specialist.

At the conclusion of this activity, participants should be able to:

 

  • Recognize lipid disorders including Homozygous Familial Hypercholesterolemia (HoFH), Imaging in Primary Prevention, Dietary Controversies, Utility of Genetic Testing in Diagnosis and Treatment, Familial Chylomicronemia Syndrome (FCS), Lipoprotein(a), Less Common Lipid Disorders, and Challenges of Weight Reduction through case discussions.
  • Describe mechanism of action, pharmacokinetics, and efficacy of approved therapies to treat lipid disorders.
  • Evaluate data from key clinical trials of lipid-altering drug therapies.
  • Diagnose complex lipid disorders.
  • Compose a treatment plan for patients with complex lipid disorders.
  • Distinguish roles in a team-based approach to care.
  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

 

CME/CE Credit Provided by the National Lipid Association 

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.5 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 12.5 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacists

Universal Activity Number – UAN JA0007192-0000-25-002-L01-P (Application)
This Activity has been approved for 12.5 contact hour(s) (1.25 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 12.5 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

 

CRITERIA FOR SUCCESS:
Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. The deadline to claim credit is June 30, 2025. Questions related to this content should be sent to cme@lipid.org.

 

FOR PHARMACISTS: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

FOR DIETITIANS: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities / materials by CDR.

COMMERCIAL SUPPORT
Full notification of commercial support will be provided in the meeting application.

DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME 

DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

PERMISSIONS
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.

Alan S. Brown, MD, MNLA

Director, Lipid Clinic
Advocate Lutheran General Hospital
Clinical Associate Professor of Medicine
Rosalind Franklin School of Medicine and Science
Loyola University
Chicago, IL

David Davidson, MD, FNLA

Clinical Educator
NorthShore Medical Group
Chicago, IL

P. Barton Duell, MD, FNLA

Professor of Medicine
Director, Sterol Analysis Laboratory
Director, LDL/Lipoprotein Apheresis Unit
Center for Preventive Cardiology
Knight Cardiovascular Institute
Division of Endocrinology, Diabetes & Clinical Nutrition
Oregon Health Sciences University
Portland, OR

Lisa Hudgins, MD

Clinical Associate Professor of Pediatrics
Weill Cornell College of Medicine
Department of Pediatric Cardiology
Pediatric Lipid Control Program
New York, NY

Dinesh Kalra, MD, FNLA

Professor & Chief of Cardiology
University of Louisville
Governor, KY Chapter of ACC
Louisville, KY

Dean Karalis, MD, FNLA

Clinical Professor of Medicine
Thomas Jefferson University Hospital
Philadelphia, PA

Jessica M. Peña, MD, MPH, FNLA

Course Co-Chair
Associate Professor of Clinical Medicine
Associate Professor of Medicine in Clinical Radiology
Director, HeartHealth, Dalio Institute of Cardiovascular Imaging
Weill Cornell Medicine and NewYork- Presbyterian Hospital
New York, NY

Katherine H. Saunders, MD

Clinical Assistant Professor of Medicine
Weill Cornell Medicine
New York, NY
Co-Founder
FlyteHealth
New Canaan, CT

James A. Underberg, MD, MS, MNLA

Course Co-Chair
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President, National Lipid Association 
Past-President, American Board of Clinical Lipidology
President, Foundation of the National Lipid Association
New York, NY

Lauren Williams, MSN, RDN, LD

Clinical Dietitian
Endocrinology – Pediatric Lipid (REACH) Clinic
Cook Children’s Medical Center
Fort Worth, TX

2025 Masters in Lipidology Course

Wednesday, May 28, 2025

Day 1

7:30 AM - 8:00 AM Registration & Breakfast
8:00 AM - 8:15 AM Course Overview James A. Underberg, MD, MS, MNLA & Jessica M. Peña, MD, FNLA
8:15 AM - 9:45 AM Consultative Case: Homozygous Familial Hypercholesterolemia (HoFH) Lisa Hudgins, MD
9:45 AM - 10:00 AM Break
10:00 AM - 11:30 PM Consultative Case: Imaging in Primary Prevention Dinesh Kalra, MD, FNLA
11:30 PM - 12:00 PM Lunch
12:00 PM - 1:30 PM Consultative Case: Dietary Controversies Lauren Williams, MCN, RDN, LD
1:30 PM - 1:45 PM Break
1:45 PM - 3:15 PM Consultative Case: Utility of Genetic Testing in Diagnosis and Treatment David Davidson, MD, FNLA
3:15 PM - 3:30 PM Break
3:30 PM - 5:00 PM Consultative Case: Familial Chylomicronemia Syndrome (FCS) Alan Brown, MD, MNLA

Thursday, May 29, 2025

Day 2

7:30 AM - 8:00 AM Breakfast
8:00 AM - 9:30 AM Consultative Case: Lipoprotein(a) Dean Karalis, MD, FNLA
9:30 AM - 9:45 AM Break
9:45 AM - 11:15 AM Consultative Case: Less Common Lipid Disorders P. Barton Duell, MD, FNLA
11:15 AM - 11:45 AM Lunch
11:45 PM - 1:15 PM Consultative Case: Challenges of Weight Reduction Katherine Saunders, MD
1:15 PM - 1:30 PM Course Wrap-Up James A. Underberg, MD, MS, MNLA & Jessica M. Peña, MD, FNLA